andriol kapszula
n.v. organon - tesztoszteron -
firmagon
ferring pharmaceuticals a/s - degarelixet - prosztatikus daganatok - endokrin terápia - firmagon is a gonadotrophin releasing hormone (gnrh) antagonist indicated:- for treatment of adult male patients with advanced hormone-dependent prostate cancer. - for treatment of high-risk localised and locally advanced hormone dependent prostate cancer in combination with radiotherapy. - as neo-adjuvant treatment prior to radiotherapy in patients with high-risk localised or locally advanced hormone dependent prostate cancer.
degarelix accord
accord healthcare s.l.u. - degarelix acetate - prosztatikus daganatok - other hormone antagonists and related agents - degarelix accord is a gonadotrophin releasing hormone (gnrh) antagonist indicated:for treatment of adult male patients with advanced hormone-dependent prostate cancer. for treatment of high-risk localised and locally advanced hormone dependent prostate cancer in combination with radiotherapy. as neo-adjuvant treatment prior to radiotherapy in patients with high-risk localised or locally advanced hormone dependent prostate cancer.
camcevi
accord healthcare s.l.u. - leuprorelin mesilate - prosztatikus daganatok - endokrin terápia - camcevi is indicated for the treatment of hormone dependent advanced prostate cancer and for the treatment of high-risk localised and locally advanced hormone dependent prostate cancer in combination with radiotherapy.
lutrate depot 3,75 mg por és oldószer retard szuszpenziós injekcióhoz
richter gedeon nyrt. - a leuprorelin -
suprefact depot 3 hónap implantátum
sanofi-aventis zrt. - buserelin -
suprefact depot 2 hónap implantátum
sanofi-aventis zrt. - buserelin -
suprefact oldatos injekció
cheplapharm arzneimittel gmbh - buserelin -
suprefact oldatos orrspray
sanofi-aventis zrt. - buserelin -
orgovyx
accord healthcare s.l.u. - relugolix - prosztatikus daganatok - endokrin terápia - orgovyx is indicated for the treatment of adult patients with advanced hormone-sensitive prostate cancer.